Advisor Group Holdings, Inc. Alector, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Alector, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 320 shares of ALEC stock, worth $614. This represents 0.0% of its overall portfolio holdings.

Number of Shares

320

Previous 1,828 82.49%

Holding current value

$614

Previous $8,000 87.5%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.34 - $6.58 $6,544 - $9,922	-1,508 Reduced 82.49%	320 $1,000
Q2 2024 Aug 13, 2024	SELL	$4.19 - $6.23 $263 - $392	-63 Reduced 3.33%	1,828 $8,000
Q1 2024 May 10, 2024	BUY	$5.69 - $8.08 $8,000 - $11,360	1,406 Added 289.9%	1,891 $11,000
Q4 2023 Feb 12, 2024	BUY	$3.77 - $8.39 $312 - $696	83 Added 20.65%	485 $3,000
Q3 2023 Nov 13, 2023	SELL	$5.2 - $8.77 $218,285 - $368,147	-41,978 Reduced 99.05%	402 $2,000
Q2 2023 Aug 10, 2023	BUY	$5.86 - $7.93 $245,123 - $331,711	41,830 Added 7605.45%	42,380 $254,000
Q1 2023 May 12, 2023	SELL	$5.85 - $9.84 $254,954 - $428,846	-43,582 Reduced 98.75%	550 $3,000
Q4 2022 Feb 10, 2023	SELL	$6.88 - $9.55 $1,190 - $1,652	-173 Reduced 0.39%	44,132 $407,000
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $357,542 - $576,259	43,656 Added 6726.66%	44,305 $419,000
Q1 2022 May 04, 2022	SELL	$13.02 - $20.78 $2,408 - $3,844	-185 Reduced 22.18%	649 $9,000
Q3 2021 Nov 05, 2021	SELL	$21.65 - $39.49 $46,244 - $84,350	-2,136 Reduced 71.92%	834 $19,000
Q2 2021 Aug 02, 2021	SELL	$15.5 - $22.48 $132,292 - $191,866	-8,535 Reduced 74.19%	2,970 $62,000
Q1 2021 May 13, 2021	BUY	$14.84 - $22.23 $170,734 - $255,756	11,505 New	11,505 $231,000
Q4 2020 Feb 10, 2021	SELL	$9.4 - $16.7 $3,760 - $6,680	-400 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.54 - $24.96 $4,216 - $9,984	400 New	400 $4,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Alector, Inc. Transaction History